Literature DB >> 15579470

Srcasm modulates EGF and Src-kinase signaling in keratinocytes.

Weijie Li1, Christine Marshall, Lijuan Mei, Leonard Dzubow, Chrysalene Schmults, Michael Dans, John Seykora.   

Abstract

The Src-activating and signaling molecule (Srcasm) is a recently described activator and substrate of Src-family tyrosine kinases (SFKs). When phosphorylated at specific tyrosines, Srcasm associates with Grb2 and p85, the regulatory subunit of phosphoinositide 3-kinase; however, little is known about the role of Srcasm in cellular signaling. Data presented here demonstrate that epidermal growth factor (EGF) receptor ligands promote the tyrosine phosphorylation of endogenous and adenovirally transduced Srcasm in keratinocytes, and that increased levels of Srcasm activate endogenous SFKs, with a preference for Fyn and Src. In addition, Srcasm potentiates EGF-dependent signals transmitted by SFKs in keratinocytes. Tyrosine phosphorylation of Srcasm is dependent on growth factors and the activity of EGFR and SFKs. Increased Srcasm expression enhances p44/42 mitogen-activated protein kinase activity and Elk-1-dependent transcriptional events. Elevated Srcasm levels inhibit keratinocyte proliferation while promoting specific aspects of keratinocyte differentiation. Lastly, Srcasm levels are decreased in human cutaneous neoplasia. Collectively, these data demonstrate that Srcasm plays a role in linking EGF receptor- and SFK-dependent signaling to differentiation in keratinocytes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15579470     DOI: 10.1074/jbc.M406546200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

1.  Curcuminoids activate p38 MAP kinases and promote UVB-dependent signalling in keratinocytes.

Authors:  Elias E Ayli; Susanne Dugas-Breit; Weijie Li; Christine Marshall; Liang Zhao; Marc Meulener; Thomas Griffin; Joel M Gelfand; John T Seykora
Journal:  Exp Dermatol       Date:  2010-04-20       Impact factor: 3.960

2.  In situ analysis of tyrosine phosphorylation networks by FLIM on cell arrays.

Authors:  Hernán E Grecco; Pedro Roda-Navarro; Andreas Girod; Jian Hou; Thomas Frahm; Dina C Truxius; Rainer Pepperkok; Anthony Squire; Philippe I H Bastiaens
Journal:  Nat Methods       Date:  2010-05-09       Impact factor: 28.547

3.  Hdac1 and Hdac2 act redundantly to control p63 and p53 functions in epidermal progenitor cells.

Authors:  Matthew LeBoeuf; Anne Terrell; Sohum Trivedi; Satrajit Sinha; Jonathan A Epstein; Eric N Olson; Edward E Morrisey; Sarah E Millar
Journal:  Dev Cell       Date:  2010-11-18       Impact factor: 12.270

4.  The adaptor protein Tom1L1 is a negative regulator of Src mitogenic signaling induced by growth factors.

Authors:  Mélanie Franco; Olivia Furstoss; Valérie Simon; Chrsitine Benistant; Wan Jing Hong; Serge Roche
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

5.  Activation of Src-family tyrosine kinases in hyperproliferative epidermal disorders.

Authors:  Elias E Ayli; Weijie Li; Tamu T Brown; Agnieszka Witkiewicz; Rosalie Elenitsas; John T Seykora
Journal:  J Cutan Pathol       Date:  2008-03       Impact factor: 1.587

6.  Prostaglandin D2 inhibits hair growth and is elevated in bald scalp of men with androgenetic alopecia.

Authors:  Luis A Garza; Yaping Liu; Zaixin Yang; Brinda Alagesan; John A Lawson; Scott M Norberg; Dorothy E Loy; Tailun Zhao; Hanz B Blatt; David C Stanton; Lee Carrasco; Gurpreet Ahluwalia; Susan M Fischer; Garret A FitzGerald; George Cotsarelis
Journal:  Sci Transl Med       Date:  2012-03-21       Impact factor: 17.956

7.  AKT induces senescence in primary esophageal epithelial cells but is permissive for differentiation as revealed in organotypic culture.

Authors:  K Oyama; T Okawa; H Nakagawa; M Takaoka; C D Andl; S-H Kim; A Klein-Szanto; J A Diehl; M Herlyn; W El-Deiry; A K Rustgi
Journal:  Oncogene       Date:  2006-10-09       Impact factor: 9.867

8.  Srcasm corrects Fyn-induced epidermal hyperplasia by kinase down-regulation.

Authors:  Weijie Li; Christine Marshall; Lijuan Mei; Joel Gelfand; John T Seykora
Journal:  J Biol Chem       Date:  2006-10-16       Impact factor: 5.157

9.  Tom1l2 hypomorphic mice exhibit increased incidence of infections and tumors and abnormal immunologic response.

Authors:  Santhosh Girirajan; Paula M Hauck; Stephen Williams; Christopher N Vlangos; Barbara B Szomju; Sara Solaymani-Kohal; Philip D Mosier; Kimber L White; Kathleen McCoy; Sarah H Elsea
Journal:  Mamm Genome       Date:  2008-03-15       Impact factor: 2.957

10.  Srcasm inhibits Fyn-induced cutaneous carcinogenesis with modulation of Notch1 and p53.

Authors:  Liang Zhao; Weijie Li; Christine Marshall; Thomas Griffin; Matthew Hanson; Ryan Hick; Tzvete Dentchev; Erik Williams; Adrienne Werth; Christopher Miller; Hasan Bashir; Warren Pear; John T Seykora
Journal:  Cancer Res       Date:  2009-12-15       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.